Human oral research · n=20
Effects of controlled exposure of sunlight on plasma and skin levels of beta-carotene.
Free radical research · 1996
Explore connectionsWhat was studied
Oral beta-carotene 30 mg/day was directly randomized against placebo. 20 healthy young women; biomarker changes do not establish protection from skin cancer or prove topical effects. High-dose supplement findings are not a recommendation.
Checked against the published abstract on Oct 1, 2026. Read the source ↗
Abstract
We conducted a randomized placebo-controlled double-blind study in 20 healthy young female students (skin type II + III, body mass index 18-22) in order to evaluate the efficacy of 10 weeks of moderate dose (30 mg/d) beta-carotene (BC) on plasma and skin beta-carotene levels during 12 days of time and intensity controlled sunlight exposure at sea level (30 degrees latitude, Red Sea, Eilath, Israel). After 12 days of controlled sun exposure (total UV dose of about 10.000J/cm2), plasma beta-carotene decreased in the placebo (p < 0.01) and beta-carotene group (not significant). In addition cutaneous beta-carotene decreased significantly in both groups. Plasma alpha-tocopherol decreased significantly (p < 0.01) during exposure time in both groups. In the supplemented group, however, the decrease of a-tocopherol was significantly greater (p < 0.01) than in the placebo group. We conclude that sunlight influences the beta-carotene and alpha-tocopherol content of blood and tissues.
Linked ingredients